Growth factor receptors are differentially expressed in cancers of the papilla of vater and pancreas

Helmut Friess, Li Wang, Zhaowen Zhu, Rolf Gerber, Michael Schröder, Akira Fukuda, Arthur Zimmermann, Murray Korc, Markus W. Büchler

Research output: Contribution to journalArticle

73 Citations (Scopus)

Abstract

Objective: To compare growth factor receptor expression in papilla of Vater cancer and pancreatic cancer. Summary Background Data: Cancer of the papilla of Vater has a much better prognosis than pancreatic cancer. Earlier symptoms may result in earlier diagnosis, but different biologic growth behaviors and genetic alterations might also be explanations. Patients and Methods: Surgical specimens from papilla of Water cancers (24 patients) and pancreatic cancers (80 patients), normal papilla of Vater tissues (20 patients), and normal pancreatic tissues (24 patients) were frozen and fixed. The authors compared the expression of the epidermal growth factor receptor (EGFR) and c-erbB2 and c-erbB3 by Northern blot, in situ hybridization, and immunohistochemistry. Results: In papilla of Vater cancer, Northern blots showed comparable EGFR and c-erbB2 mRNA expression but significantly lower c- erbB3 mRNA levels than in normal papilla. In pancreatic cancer, mRNA expression was enhanced compared with normal controls for EGFR (4-fold), c- erbB2 (2.5-fold), and c-erbB3 (5.2-fold). In situ hybridization confirmed this and showed mRNA expression only in cancer cells. EGFR immunohistochemical staining scores were comparable in papilla of Vater cancer (1.17 ± 0.22) and normal papilla (1.42 ± 0.25). Staining scores for c-erbB2 (2.72 ± 0.40 vs. 3.89 ± 0.37) and c-erbB3 (2.78 ± 0.35 vs. 3.89 ± 0.53) were slightly lower than controls in papilla of Vater cancer. In pancreatic cancer, immunostaining scores for EGFR, c-erbB2, and c-erbB3 were significantly higher than controls. Conclusion: Members of the EGFR family show similar or lower expression in papilla of Vater cancer than in normal controls. In pancreatic cancer, these receptors are upregulated. This supports the hypothesis that papilla of Vater cancer and pancreatic cancer have biologic differences that may contribute to the different growth of these tumors.

Original languageEnglish (US)
Pages (from-to)767-775
Number of pages9
JournalAnnals of Surgery
Volume230
Issue number6
DOIs
StatePublished - Dec 1999
Externally publishedYes

Fingerprint

Growth Factor Receptors
Pancreas
Pancreatic Neoplasms
Epidermal Growth Factor Receptor
Neoplasms
Messenger RNA
Northern Blotting
In Situ Hybridization
Staining and Labeling
Growth
Early Diagnosis
Immunohistochemistry

ASJC Scopus subject areas

  • Surgery

Cite this

Friess, H., Wang, L., Zhu, Z., Gerber, R., Schröder, M., Fukuda, A., ... Büchler, M. W. (1999). Growth factor receptors are differentially expressed in cancers of the papilla of vater and pancreas. Annals of Surgery, 230(6), 767-775. https://doi.org/10.1097/00000658-199912000-00005

Growth factor receptors are differentially expressed in cancers of the papilla of vater and pancreas. / Friess, Helmut; Wang, Li; Zhu, Zhaowen; Gerber, Rolf; Schröder, Michael; Fukuda, Akira; Zimmermann, Arthur; Korc, Murray; Büchler, Markus W.

In: Annals of Surgery, Vol. 230, No. 6, 12.1999, p. 767-775.

Research output: Contribution to journalArticle

Friess, H, Wang, L, Zhu, Z, Gerber, R, Schröder, M, Fukuda, A, Zimmermann, A, Korc, M & Büchler, MW 1999, 'Growth factor receptors are differentially expressed in cancers of the papilla of vater and pancreas', Annals of Surgery, vol. 230, no. 6, pp. 767-775. https://doi.org/10.1097/00000658-199912000-00005
Friess, Helmut ; Wang, Li ; Zhu, Zhaowen ; Gerber, Rolf ; Schröder, Michael ; Fukuda, Akira ; Zimmermann, Arthur ; Korc, Murray ; Büchler, Markus W. / Growth factor receptors are differentially expressed in cancers of the papilla of vater and pancreas. In: Annals of Surgery. 1999 ; Vol. 230, No. 6. pp. 767-775.
@article{9a953dd2773c4e5bac27737731135fb9,
title = "Growth factor receptors are differentially expressed in cancers of the papilla of vater and pancreas",
abstract = "Objective: To compare growth factor receptor expression in papilla of Vater cancer and pancreatic cancer. Summary Background Data: Cancer of the papilla of Vater has a much better prognosis than pancreatic cancer. Earlier symptoms may result in earlier diagnosis, but different biologic growth behaviors and genetic alterations might also be explanations. Patients and Methods: Surgical specimens from papilla of Water cancers (24 patients) and pancreatic cancers (80 patients), normal papilla of Vater tissues (20 patients), and normal pancreatic tissues (24 patients) were frozen and fixed. The authors compared the expression of the epidermal growth factor receptor (EGFR) and c-erbB2 and c-erbB3 by Northern blot, in situ hybridization, and immunohistochemistry. Results: In papilla of Vater cancer, Northern blots showed comparable EGFR and c-erbB2 mRNA expression but significantly lower c- erbB3 mRNA levels than in normal papilla. In pancreatic cancer, mRNA expression was enhanced compared with normal controls for EGFR (4-fold), c- erbB2 (2.5-fold), and c-erbB3 (5.2-fold). In situ hybridization confirmed this and showed mRNA expression only in cancer cells. EGFR immunohistochemical staining scores were comparable in papilla of Vater cancer (1.17 ± 0.22) and normal papilla (1.42 ± 0.25). Staining scores for c-erbB2 (2.72 ± 0.40 vs. 3.89 ± 0.37) and c-erbB3 (2.78 ± 0.35 vs. 3.89 ± 0.53) were slightly lower than controls in papilla of Vater cancer. In pancreatic cancer, immunostaining scores for EGFR, c-erbB2, and c-erbB3 were significantly higher than controls. Conclusion: Members of the EGFR family show similar or lower expression in papilla of Vater cancer than in normal controls. In pancreatic cancer, these receptors are upregulated. This supports the hypothesis that papilla of Vater cancer and pancreatic cancer have biologic differences that may contribute to the different growth of these tumors.",
author = "Helmut Friess and Li Wang and Zhaowen Zhu and Rolf Gerber and Michael Schr{\"o}der and Akira Fukuda and Arthur Zimmermann and Murray Korc and B{\"u}chler, {Markus W.}",
year = "1999",
month = "12",
doi = "10.1097/00000658-199912000-00005",
language = "English (US)",
volume = "230",
pages = "767--775",
journal = "Annals of Surgery",
issn = "0003-4932",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Growth factor receptors are differentially expressed in cancers of the papilla of vater and pancreas

AU - Friess, Helmut

AU - Wang, Li

AU - Zhu, Zhaowen

AU - Gerber, Rolf

AU - Schröder, Michael

AU - Fukuda, Akira

AU - Zimmermann, Arthur

AU - Korc, Murray

AU - Büchler, Markus W.

PY - 1999/12

Y1 - 1999/12

N2 - Objective: To compare growth factor receptor expression in papilla of Vater cancer and pancreatic cancer. Summary Background Data: Cancer of the papilla of Vater has a much better prognosis than pancreatic cancer. Earlier symptoms may result in earlier diagnosis, but different biologic growth behaviors and genetic alterations might also be explanations. Patients and Methods: Surgical specimens from papilla of Water cancers (24 patients) and pancreatic cancers (80 patients), normal papilla of Vater tissues (20 patients), and normal pancreatic tissues (24 patients) were frozen and fixed. The authors compared the expression of the epidermal growth factor receptor (EGFR) and c-erbB2 and c-erbB3 by Northern blot, in situ hybridization, and immunohistochemistry. Results: In papilla of Vater cancer, Northern blots showed comparable EGFR and c-erbB2 mRNA expression but significantly lower c- erbB3 mRNA levels than in normal papilla. In pancreatic cancer, mRNA expression was enhanced compared with normal controls for EGFR (4-fold), c- erbB2 (2.5-fold), and c-erbB3 (5.2-fold). In situ hybridization confirmed this and showed mRNA expression only in cancer cells. EGFR immunohistochemical staining scores were comparable in papilla of Vater cancer (1.17 ± 0.22) and normal papilla (1.42 ± 0.25). Staining scores for c-erbB2 (2.72 ± 0.40 vs. 3.89 ± 0.37) and c-erbB3 (2.78 ± 0.35 vs. 3.89 ± 0.53) were slightly lower than controls in papilla of Vater cancer. In pancreatic cancer, immunostaining scores for EGFR, c-erbB2, and c-erbB3 were significantly higher than controls. Conclusion: Members of the EGFR family show similar or lower expression in papilla of Vater cancer than in normal controls. In pancreatic cancer, these receptors are upregulated. This supports the hypothesis that papilla of Vater cancer and pancreatic cancer have biologic differences that may contribute to the different growth of these tumors.

AB - Objective: To compare growth factor receptor expression in papilla of Vater cancer and pancreatic cancer. Summary Background Data: Cancer of the papilla of Vater has a much better prognosis than pancreatic cancer. Earlier symptoms may result in earlier diagnosis, but different biologic growth behaviors and genetic alterations might also be explanations. Patients and Methods: Surgical specimens from papilla of Water cancers (24 patients) and pancreatic cancers (80 patients), normal papilla of Vater tissues (20 patients), and normal pancreatic tissues (24 patients) were frozen and fixed. The authors compared the expression of the epidermal growth factor receptor (EGFR) and c-erbB2 and c-erbB3 by Northern blot, in situ hybridization, and immunohistochemistry. Results: In papilla of Vater cancer, Northern blots showed comparable EGFR and c-erbB2 mRNA expression but significantly lower c- erbB3 mRNA levels than in normal papilla. In pancreatic cancer, mRNA expression was enhanced compared with normal controls for EGFR (4-fold), c- erbB2 (2.5-fold), and c-erbB3 (5.2-fold). In situ hybridization confirmed this and showed mRNA expression only in cancer cells. EGFR immunohistochemical staining scores were comparable in papilla of Vater cancer (1.17 ± 0.22) and normal papilla (1.42 ± 0.25). Staining scores for c-erbB2 (2.72 ± 0.40 vs. 3.89 ± 0.37) and c-erbB3 (2.78 ± 0.35 vs. 3.89 ± 0.53) were slightly lower than controls in papilla of Vater cancer. In pancreatic cancer, immunostaining scores for EGFR, c-erbB2, and c-erbB3 were significantly higher than controls. Conclusion: Members of the EGFR family show similar or lower expression in papilla of Vater cancer than in normal controls. In pancreatic cancer, these receptors are upregulated. This supports the hypothesis that papilla of Vater cancer and pancreatic cancer have biologic differences that may contribute to the different growth of these tumors.

UR - http://www.scopus.com/inward/record.url?scp=0033497861&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033497861&partnerID=8YFLogxK

U2 - 10.1097/00000658-199912000-00005

DO - 10.1097/00000658-199912000-00005

M3 - Article

C2 - 10615931

AN - SCOPUS:0033497861

VL - 230

SP - 767

EP - 775

JO - Annals of Surgery

JF - Annals of Surgery

SN - 0003-4932

IS - 6

ER -